Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » NASH

NASH

ADVERTISEMENT
In Depth

Is a Treatment for NASH Finally on the Horizon?

Despite several high-profile trial failures in the field, multiple players are getting close to the…

By Clara Rodríguez Fernández
02/03/2022 - 6 minutes
Sponsored by Medpace

Infographic: The Key Role of Imaging in Clinical Trials

Medical imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), and ultrasound have…

By Maya Chergova
26/01/2021 - 2 minutes
News and Trends

Genfit’s Phase III Drug Fails to Treat NASH, But New Players On Horizon

Patients with the chronic liver disease NASH must now wait even longer for an approved…

By Helen Albert
13/05/2020 - 4 minutes
News and Trends

NorthSea Therapeutics Raises €36M to Complete NASH Phase II Trial

The Dutch biotech NorthSea Therapeutics has raised a €36M ($40M) Series B round to fund…

By Jonathan Smith
08/01/2020 - 2 minutes
News and Trends

Update: Cell Therapy Biotech Raises €47M to Fund NASH Clinical Trial

Update (17/12/2019): Promethera has increased the total raised in its Series D round to €47.2M…

By Jonathan Smith
17/12/2019 - 2 minutes
Sponsored

Treating Liver Diseases: Is This Preclinical Model the Solution?

Liver diseases are on the rise. Although many drug candidates are being developed, preclinical toxicity,…

By Larissa Warneck-Silvestrin
04/12/2019 - 6 minutes
Sponsored

Can This Cell Therapy Help Fight the NASH Epidemic?

Nonalcoholic steatohepatitis (NASH) is the most severe form of nonalcoholic fatty liver disease (NAFLD) and…

By Larissa Warneck-Silvestrin
04/11/2019 - 7 minutes
Interview

The First Approved NASH Therapy?

Genfit is poised to become the first company to get a treatment for NASH to…

By Helen Albert
30/07/2019 - 6 minutes
News and Trends

Genfit’s NASH Drug to Be Developed in China in Deal Worth up to €200M

The US-Chinese company Terns Pharmaceuticals will develop and commercialize Genfit’s phase III drug elafibranor for…

By Jonathan Smith
25/06/2019 - 3 minutes
News and Trends

First Stem Cell Therapy for Liver Failure Shows Promise in First Human Trials

A stem cell therapy developed by the Belgian company Promethera has improved symptoms, such as…

By Jonathan Smith
15/04/2019 - 2 minutes
News and Trends

Genfit Gets Ready to Launch Drug for Untreated Liver Disease Raising €120M

After some big failures from its top competitors earlier this year, French company Genfit has…

By Clara Rodríguez Fernández
27/03/2019 - 3 minutes
In Depth

The European Fight Against NASH, The Silent Liver Disease

Today is the First International NASH Day, and to mark the occasion, we bring you…

By Karen O’Hanlon Cohrt
12/06/2018 - 9 minutes
  • 1
  • 2
  • 3
  • 4
  • Next Page »
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast